Home/Filings/4/0001209191-22-010886
4//SEC Filing

Daniels Kevin 4

Accession 0001209191-22-010886

CIK 0001000229other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 5:14 PM ET

Size

5.7 KB

Accession

0001209191-22-010886

Insider Transaction Report

Form 4
Period: 2022-02-17
Daniels Kevin
CAO & Treasurer
Transactions
  • Award

    Performance Shares

    2022-02-17+9,5009,500 total
    Exercise: $0.00Common Shares (9,500 underlying)
Footnotes (1)
  • [F1]Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, this award would vest at the end of a three-year performance period that began on January 1, 2022 and ends on December 31, 2024 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as measured and determined by the Compensation Committee at the end of the Performance Period.

Issuer

CORE LABORATORIES N V

CIK 0001000229

Entity typeother

Related Parties

1
  • filerCIK 0001740507

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:14 PM ET
Size
5.7 KB